Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.1 (
protein kinase
)
81,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
VIT32
, a vasopressin-induced transcript, inhibits Na(+) transport when coexpressed with the epithelial sodium channel in Xenopus laevis oocytes (EMBO J 21: 5109-5117, 2002). To understand the mechanism of
VIT32
gene regulation, we examined the effect of DDAVP and cAMP stimulation on
VIT32
expression in M-1 mouse collecting duct cells and in H441 human airway epithelial cells. Elevation of cAMP with forskolin and IBMX increased
VIT32
gene expression with a peak effect at 2 h. The increase in gene expression was abolished by H89 and by actinomycin D, suggesting that cAMP stimulates
VIT32
mRNA expression by a
PKA
-mediated increase in gene transcription. An approximately 1.5-kb fragment of the 5'-flanking region of
VIT32
was cloned and was able to confer cAMP-stimulated reporter gene activity when transfected into M-1 and H441 cells. By deletion analysis and site-directed mutagenesis, a cAMP response element (CRE) was identified within the proximal promoter region that was sufficient to account for the increase in
VIT32
gene expression seen with DDAVP and elevation of cAMP. Furthermore, DDAVP-stimulated
VIT32
promoter-reporter activity was inhibited by H89 and by a dominant negative CREB construct. Finally, we were able to identify CREB as a nuclear protein that bound to the
VIT32
CRE in gel mobility shift assays. In summary, DDAVP stimulates transcription of
VIT32
via a CRE within the proximal promoter region of the
VIT32
gene.
...
PMID:AVP-induced VIT32 gene expression in collecting duct cells occurs via trans-activation of a CRE in the 5'-flanking region of the VIT32 gene. 1514 Jul 62